ArticleF1000Research2021
Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020.
Open access · goldAbstract read
In one paragraph
Article in F1000Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 14 citations in OpenAlex.
- Article
- Risk factors for long COVID among participants of a population-based study in urban and rural Kenya, 2021.BMC public health · 2025Article
- Article
- SARS-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemic.BMC public health · 2024Article
- Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.Gates open research · 2024Article
- Comparative performance of the InBios SCoV-2 DetectWellcome open research · 2024Article
- Transmission of SARS-CoV-2 among underserved pastoralist communities in Kajiado County, Kenya: 2020-2022.PloS one · 2024Article
- Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021.Gates open research · 2023Article
- Estimating excess mortality during the COVID-19 pandemic from a population-based infectious disease surveillance in two diverse populations in Kenya, March 2020-December 2021.PLOS global public health · 2023Article
- Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal.Vaccines · 2022Article
- Dynamics of SARS-CoV-2 exposure in Malawian infants between February 2020 and May 2021.Journal of clinical virology plus · 2022Article
- SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.PLOS global public health · 2022Article
- Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020.F1000Research · 2021Article
- Epidemiology and response to the COVID-19 pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020-December 2022.Travel medicine and infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 3 institutions in 2 countries.
Patrick K MunywokiCenter for Global Health, Division of Public Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, USA.ORCID 0000-0001-9419-7155
Caroline NasimiyuGlobal Health Kenya, Washington State University, Nairobi, USA.
Moshe Dayan AlandoCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Nancy OtienoCentre for Global Health Research,, Kenya Medical Research Institute, Kisumu, Kenya.
Cynthia OmbokGlobal Health Kenya, Washington State University, Nairobi, USA.
Ruth NjorogeGlobal Health Kenya, Washington State University, Nairobi, USA.
Gilbert KikwaiCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Dennis OdhiamboCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Mike Powel OsitaCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Alice OumaCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Clifford OdourCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Bonventure JumaCenter for Global Health, Division of Public Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, USA.
Caroline A OchiengCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Immaculate MutisyaCenter for Global Health, Division of Public Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, USA.
Isaac NgereGlobal Health Kenya, Washington State University, Nairobi, USA.
Jeanette DawaGlobal Health Kenya, Washington State University, Nairobi, USA.
Eric OsoroGlobal Health Kenya, Washington State University, Nairobi, USA.
M Kariuki NjengaGlobal Health Kenya, Washington State University, Nairobi, USA.
Godfrey BigogoCentre for Global Health Research,, Kenya Medical Research Institute, Kisumu, Kenya.
Peninah MunyuaCenter for Global Health, Division of Public Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, USA.
Terrence Q LoCenter for Global Health, Division of Public Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, USA.
Elizabeth HunspergerCenter for Global Health, Division of Public Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, USA.
Amy Herman-RoloffCenter for Global Health, Division of Public Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, USA.
Kenya Medical Research Institute · KECenter for Global Health · USWashington State Department of Health · US
Funding
Emerging Infectious Diseases Research Center - East and Central AfricaU01AI151799 · NIAID · WASHINGTON STATE UNIVERSITY · PI M KARIUKI NJENGA · 2020 to 2026
$10.4MZoonotic and Emerging Infectious Diseases Training ProgramD43TW011519 · FIC · WASHINGTON STATE UNIVERSITY · PI Walter Godfrey Jaoko, Thumbi Mwangi · 2020 to 2026
$1.2MCGH CDC HHS U01 GH002143FIC NIH HHS D43 TW011519NIAID NIH HHS U01 AI151799
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19AdultAntibodies, ViralChildChild, PreschoolCOVID-19 VaccinesHumansKenyaPandemicsRisk FactorsSARS-CoV-2Seroepidemiologic StudiesSpike Glycoprotein, CoronavirusAntibodies, ViralCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19HouseholdsIgM and IgGKenyaKiberaPopulation-basedSARS-CoV-2SerologySerosurveyurban informal settlement
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.